- Home
- ROIV vs NFG Comparison
ROIV vs NFG Comparison
Compare ROIV & NFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- NFG
- Stock Information
- Founded
- ROIV 2014
- NFG 1902
- Country
- ROIV United Kingdom
- NFG United States
- Employees
- ROIV N/A
- NFG N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- NFG Oil/Gas Transmission
- Sector
- ROIV Health Care
- NFG Utilities
- Exchange
- ROIV Nasdaq
- NFG Nasdaq
- Market Cap
- ROIV 8.4B
- NFG 7.0B
- IPO Year
- ROIV N/A
- NFG N/A
- Fundamental
- Price
- ROIV $10.79
- NFG $81.19
- Analyst Decision
- ROIV Buy
- NFG Buy
- Analyst Count
- ROIV 4
- NFG 2
- Target Price
- ROIV $17.50
- NFG $81.00
- AVG Volume (30 Days)
- ROIV 5.9M
- NFG 662.1K
- Earning Date
- ROIV 05-29-2025
- NFG 04-30-2025
- Dividend Yield
- ROIV N/A
- NFG 2.54%
- EPS Growth
- ROIV N/A
- NFG N/A
- EPS
- ROIV N/A
- NFG 0.43
- Revenue
- ROIV $122,585,000.00
- NFG $2,068,941,000.00
- Revenue This Year
- ROIV N/A
- NFG $29.58
- Revenue Next Year
- ROIV N/A
- NFG $10.60
- P/E Ratio
- ROIV N/A
- NFG $190.25
- Revenue Growth
- ROIV 140.04
- NFG 5.94
- 52 Week Low
- ROIV $8.73
- NFG $53.03
- 52 Week High
- ROIV $13.06
- NFG $82.70
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- NFG 57.85
- Support Level
- ROIV $10.58
- NFG $78.23
- Resistance Level
- ROIV $11.77
- NFG $81.50
- Average True Range (ATR)
- ROIV 0.34
- NFG 1.81
- MACD
- ROIV -0.07
- NFG -0.09
- Stochastic Oscillator
- ROIV 17.65
- NFG 71.65
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.